Market Performance

Serina Therapeutics (ticker: SER) closed 6.25 % lower on the 24‑hour period ending 02:12 PM Central Europe time on Monday, 26 November 2026. The share price at that time was USD 1.65. The company’s total outstanding shares amount to 25.4 million.

Market capitalization is USD 41.9 million. In the last 24 hours, the trading volume was approximately USD 13.2 k. Since the end of last month, the share price has fallen 22.9 %. The simple moving average over the last 200 days is USD 2.11. The 52‑week high was USD 5.09 on 28 October 2025, while the 52‑week low was USD 1.22 on 18 March 2026.

Peer Performance

The following related companies have exhibited the following 24‑hour price movements:

  • Fluence (4SVE.F) – unchanged; trades at EUR 0.04; market cap EUR 43.5 million.
  • Sensus Healthcare (SRTS) – up 2.79 %; trades at USD 2.95; market cap USD 48.6 million.
  • Xilio Therapeutics (XLO) – down 5.73 %; trades at USD 7.57; market cap USD 49.8 million.
  • Rein Therapeutics (RNTX) – down 3.32 %; trades at USD 0.58; market cap USD 50.2 million.
  • Elicio Therapeutics (9HA.F) – down 12.36 %; trades at USD 1.90; market cap USD 49.9 million.

Company Overview

Serina Therapeutics, Inc. (ticker: SER) is a biotechnology company focused on cell‑immortality and regenerative‑biology technologies. The company develops therapeutic products aimed at treating aging and age‑related diseases. It operates within the Health Care sector, is headquartered in Alameda, United States, and serves patients primarily in the state of California. More information about the company and its product pipeline can be found on its website at www.agexinc.com . The stock is listed on the NYSE MKT and was first offered to the public on 29 November 2018.